It is reported that the organic sales of medical device supplier Stryker (Stryker) is in line with the trend of the US orthopedic market, and has achieved sustained growth of no less than 5% in ten quarters. Although weak international sales caused Stryker's third-quarter sales to fall to 5.3% compared to 6.9% in the second quarter, Stryker President and CEO Kevin Lobo said that all three business units have achieved The year-on-year increase was mainly due to the strong US bone power system and corporate diversification model.
Stryker’s profit was $301 million, or 79 cents per share, and sales in the third quarter reached $2.42 billion. Lobo said 70% of total sales came from the US market.
According to market intelligence companies, the orthopaedic device market is expected to become the protagonist of the global medical device industry . In the next five years, sales in the orthopedic field will rank third, second only to cardiology and in vitro diagnostics.
Kristen Stewart, a Deutsche Bank analyst, said in a US conference call to the Stryker Financial Times: "This quarter's business performance is very gratifying, especially in the hip and knee franchise."
Excluding the impact of foreign exchange and acquisitions, Stryker's third quarter orthopaedic sales increased to 5.5% compared to 5.3% in the second quarter. Compared with the 8.3% in the second quarter, the US market grew to 9% in the third quarter, which made up for the weakness of the international market. Among them, the international market sales in the second quarter was 3%, while sales in the third quarter fell to 0.5%. Lobo orthopedic sales accounted for 42% of the company's total sales in the third quarter.
Last Friday, US Stryker shares (NYSE: SYK) fell 4.15%, closing price was 94.44 US dollars, the average trading volume was 3601564 shares. The price of the stock has fluctuated between $83.29 and $105.34 over the past 52 weeks.
Mako Surgical Robot
The US FDA abandoned the Stryker Mako surgical robot for total knee replacement in August, so the offer for Mako surgical knee and hip applications has increased. In the third quarter, the company sold 17 Mako surgical robots, up from 13 in the second quarter. Stryker said it plans to launch Mako's full knee application by the end of the year. The company currently has 41 Mako systems.
Nano Gel Pad,Nano Adhesive Tape,Nano Gel Grip Tape,Washable Adhesive Tape
Kunshan Jieyudeng Intelligent Technology Co., Ltd. , https://www.jerrytapes.com